Back to Search
Start Over
P-89 The correlation between adverse events and survival benefits of donafenib in the first-line treatment of advanced hepatocellular carcinoma.
- Source :
-
Annals of Oncology . 2021 Supplement 3, Vol. 32, pS128-S128. 1p. - Publication Year :
- 2021
- Subjects :
- *ENZYME inhibitors
*HEPATOCELLULAR carcinoma
*CLINICAL trials
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 32
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152686683
- Full Text :
- https://doi.org/10.1016/j.annonc.2021.05.144